Vivos (RDGL) Enterprise Value Growth (5y) (2015 - 2025)
Vivos (RDGL) Enterprise Value Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.52% |
| Sep 30, 2025 | -171.48% |
| Jun 30, 2025 | -60.62% |
| Dec 31, 2024 | -155.35% |
| Sep 30, 2024 | -50.35% |
| Jun 30, 2024 | -189.35% |
| Mar 31, 2024 | -100.99% |
| Dec 31, 2023 | -210.76% |
| Mar 31, 2023 | -875.37% |
| Dec 31, 2022 | -190.01% |
| Sep 30, 2022 | -145.90% |
| Jun 30, 2022 | -23.25% |
| Mar 31, 2022 | -120.01% |
| Dec 31, 2021 | -124.94% |
| Sep 30, 2021 | -957.80% |
| Jun 30, 2021 | -552.51% |
| Mar 31, 2021 | -58.90% |
| Dec 31, 2020 | -38.24% |
| Sep 30, 2020 | -15.09% |
| Jun 30, 2020 | -56.83% |